BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35724268)

  • 21. Age of islet autoantibody appearance and mean levels of insulin, but not GAD or IA-2 autoantibodies, predict age of diagnosis of type 1 diabetes: diabetes autoimmunity study in the young.
    Steck AK; Johnson K; Barriga KJ; Miao D; Yu L; Hutton JC; Eisenbarth GS; Rewers MJ
    Diabetes Care; 2011 Jun; 34(6):1397-9. PubMed ID: 21562325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Normal but increasing hemoglobin A1c levels predict progression from islet autoimmunity to overt type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY).
    Stene LC; Barriga K; Hoffman M; Kean J; Klingensmith G; Norris JM; Erlich HA; Eisenbarth GS; Rewers M
    Pediatr Diabetes; 2006 Oct; 7(5):247-53. PubMed ID: 17054445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility.
    Pöllänen PM; Lempainen J; Laine AP; Toppari J; Veijola R; Vähäsalo P; Ilonen J; Siljander H; Knip M
    Diabetologia; 2017 Jul; 60(7):1284-1293. PubMed ID: 28364254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of slow progression to diabetes in multiple islet autoantibody-positive individuals from five longitudinal cohorts: the SNAIL study.
    Long AE; Wilson IV; Becker DJ; Libman IM; Arena VC; Wong FS; Steck AK; Rewers MJ; Yu L; Achenbach P; Casas R; Ludvigsson J; Williams AJK; Gillespie KM
    Diabetologia; 2018 Jun; 61(6):1484-1490. PubMed ID: 29532109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What Have Slow Progressors Taught Us About T1D-Mind the Gap!
    Gillespie KM; Long AE
    Curr Diab Rep; 2019 Sep; 19(10):99. PubMed ID: 31501992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamics of Islet Autoantibodies During Prospective Follow-Up From Birth to Age 15 Years.
    Pöllänen PM; Ryhänen SJ; Toppari J; Ilonen J; Vähäsalo P; Veijola R; Siljander H; Knip M
    J Clin Endocrinol Metab; 2020 Dec; 105(12):e4638-51. PubMed ID: 32882033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting Islet Cell Autoimmunity and Type 1 Diabetes: An 8-Year TEDDY Study Progress Report.
    Krischer JP; Liu X; Vehik K; Akolkar B; Hagopian WA; Rewers MJ; She JX; Toppari J; Ziegler AG; Lernmark Å;
    Diabetes Care; 2019 Jun; 42(6):1051-1060. PubMed ID: 30967432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Multifactorial Progression from the Islet Autoimmunity to Type 1 Diabetes in Children.
    Bauer W; Gyenesei A; Krętowski A
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proinsulin/Insulin autoantibodies measured with electrochemiluminescent assay are the earliest indicator of prediabetic islet autoimmunity.
    Yu L; Dong F; Miao D; Fouts AR; Wenzlau JM; Steck AK
    Diabetes Care; 2013 Aug; 36(8):2266-70. PubMed ID: 23423694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel approach for the analysis of longitudinal profiles reveals delayed progression to type 1 diabetes in a subgroup of multiple-islet-autoantibody-positive children.
    Endesfelder D; Hagen M; Winkler C; Haupt F; Zillmer S; Knopff A; Bonifacio E; Ziegler AG; Zu Castell W; Achenbach P
    Diabetologia; 2016 Oct; 59(10):2172-80. PubMed ID: 27400691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accelerated progression from islet autoimmunity to diabetes is causing the escalating incidence of type 1 diabetes in young children.
    Ziegler AG; Pflueger M; Winkler C; Achenbach P; Akolkar B; Krischer JP; Bonifacio E
    J Autoimmun; 2011 Aug; 37(1):3-7. PubMed ID: 21376535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Childhood Height Growth Rate Association With the Risk of Islet Autoimmunity and Development of Type 1 Diabetes.
    Li Z; Veijola R; Koski E; Anand V; Martin F; Waugh K; Hyöty H; Winkler C; Killian MB; Lundgren M; Ng K; Maziarz M; Toppari J
    J Clin Endocrinol Metab; 2022 May; 107(6):1520-1528. PubMed ID: 35244713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identical and Nonidentical Twins: Risk and Factors Involved in Development of Islet Autoimmunity and Type 1 Diabetes.
    Triolo TM; Fouts A; Pyle L; Yu L; Gottlieb PA; Steck AK;
    Diabetes Care; 2019 Feb; 42(2):192-199. PubMed ID: 30061316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accelerated Progression to Type 1 Diabetes in the Presence of
    Balke EM; Balti EV; Van der Auwera B; Weets I; Costa O; Demeester S; Abrams P; Casteels K; Coeckelberghs M; Tenoutasse S; Keymeulen B; Pipeleers DG; Gorus FK;
    Diabetes Care; 2018 May; 41(5):1076-1083. PubMed ID: 29545461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence of islet cell autoimmunity in elderly patients with type 2 diabetes.
    Pietropaolo M; Barinas-Mitchell E; Pietropaolo SL; Kuller LH; Trucco M
    Diabetes; 2000 Jan; 49(1):32-8. PubMed ID: 10615947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Omega-3 polyunsaturated fatty acid intake and islet autoimmunity in children at increased risk for type 1 diabetes.
    Norris JM; Yin X; Lamb MM; Barriga K; Seifert J; Hoffman M; Orton HD; Barón AE; Clare-Salzler M; Chase HP; Szabo NJ; Erlich H; Eisenbarth GS; Rewers M
    JAMA; 2007 Sep; 298(12):1420-8. PubMed ID: 17895458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating metabolites in progression to islet autoimmunity and type 1 diabetes.
    Lamichhane S; Kemppainen E; Trošt K; Siljander H; Hyöty H; Ilonen J; Toppari J; Veijola R; Hyötyläinen T; Knip M; Orešič M
    Diabetologia; 2019 Dec; 62(12):2287-2297. PubMed ID: 31444528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is presence of islet autoantibodies at birth associated with development of persistent islet autoimmunity? The Diabetes Autoimmunity Study in the Young (DAISY).
    Stanley HM; Norris JM; Barriga K; Hoffman M; Yu L; Miao D; Erlich HA; Eisenbarth GS; Rewers M;
    Diabetes Care; 2004 Feb; 27(2):497-502. PubMed ID: 14747235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel genetic risk factors influence progression of islet autoimmunity to type 1 diabetes.
    Onengut-Gumuscu S; Paila U; Chen WM; Ratan A; Zhu Z; Steck AK; Frohnert BI; Waugh KC; Webb-Robertson BM; Norris JM; Lange LA; Rewers MJ; Rich SS
    Sci Rep; 2020 Nov; 10(1):19193. PubMed ID: 33154504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early childhood CMV infection may decelerate the progression to clinical type 1 diabetes.
    Ekman I; Vuorinen T; Knip M; Veijola R; Toppari J; Hyöty H; Kinnunen T; Ilonen J; Lempainen J
    Pediatr Diabetes; 2019 Feb; 20(1):73-77. PubMed ID: 30338642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.